Abnormal Auditory Processing and Underlying Structural Changes in 22q11.2 Deletion Syndrome.

Cantonas LM
Mancini V
Rihs TA
Rochas V
Schneider M
Eliez S
Michel CM
Scientific Abstract

The 22q11.2 deletion syndrome (22q11.2 DS), one of the highest genetic risk for the development of schizophrenia, offers a unique opportunity to understand neurobiological and functional changes preceding the onset of the psychotic illness. Reduced auditory mismatch negativity response (MMN) has been proposed as a promising index of abnormal sensory processing and brain pathology in schizophrenia. However, the link between the MMN response and its underlying cerebral mechanisms in 22q11.2 DS remains unexamined. We measured auditory-evoked potentials to frequency deviant stimuli with high-density electroencephalogram and volumetric estimates of cortical and thalamic auditory areas with structural T1-weighted magnetic resonance imaging in a sample of 130 individuals, 70 with 22q11.2 DS and 60 age-matched typically developing (TD) individuals. Compared to TD group, the 22q11.2 deletion carriers reveal reduced MMN response and significant changes in topographical maps and decreased gray matter volumes of cortical and subcortical auditory areas, however, without any correlations between MMN alteration and structural changes. Furthermore, exploratory research on the presence of hallucinations (H+\H-) reveals no change in MMN response in 22q11.2DS (H+ and H-) as compared to TD individuals. Nonetheless, we observe bilateral volume reduction of the superior temporal gyrus and left medial geniculate in 22q11.2DSH+ as compared to 22q11.2DSH- and TD participants. These results suggest that the mismatch response might be a promising neurophysiological marker of functional changes within the auditory pathways that might underlie elevated risk for the development of psychotic symptoms.

Citation

2021. Schizophr Bull, 47(1):189-196.

DOI
10.1093/schbul/sbaa104
Related Content
Publication
McClelland VM, Cvetkovic Z, Lin JP, Mills KR, Brown P
2020. Clin. Neurophysiol., 131(4):967-977.
Publication
Barron HC, Reeve HM, Koolschijn RS, Perestenko PV, Shpektor A, Nili H, Rothaermel R, Campo-Urriza N, O'Reilly JX, Bannerman DM, Behrens TE, Dupret D
2020. Cell, 183(1):228-243.e21.
Publication
Garas FN, Kormann E, Shah RS, Vinciati F, Smith Y, Magill PJ, Sharott A
2018. J. Comp. Neurol., 526(5):877-898.
Publication
Reis C, Sharott A, Magill PJ, van Wijk B, Parr T, Zeidman P, Friston KJ, Cagnan H
2019. Neuroimage, 193:103-114.
Publication
Xie X, Zhang D, Yu T, Duan Y, Daly I, He S

2023. Front Hum Neurosci, 17:1280281.